Pulsatile blood flow through the cavities of the heart and great vessels is time-varying and
multidirectional. Access to all regions, phases and directions of cardiovascular flows has …

Pulmonary hypertension (PH) is a heterogeneous and fatal disease of the lung vasculature,
where metabolic and mitochondrial dysfunction may drive pathogenesis. Similar to the …

Magnetic resonance imaging (MRI) has become an important tool for the clinical evaluation
of patients with cardiac and vascular diseases. Since its introduction in the late 1980s …

Magnetic resonance imaging (MRI) techniques provide non-invasive and non-ionising
methods for the highly accurate anatomical depiction of the heart and vessels throughout the …

Pulmonary hypertension (PH) remains a challenging condition to diagnose, classify and
treat. Current approaches to the assessment of PH include echocardiography …

Imaging plays a central role in the diagnosis and management of all forms of pulmonary
hypertension (PH). Although Doppler echocardiography is essential for the evaluation of PH …

Pulmonary hypertension (PH) is an often-fatal vascular disease of unclear molecular origins.
The pulmonary vascular remodelling which occurs in PH is characterised by elevated …

Background Doppler echocardiography (echo) is the reference standard for blood flow
velocity analysis, and two-dimensional (2-D) phase-contrast magnetic resonance imaging …

Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling
resulting in right ventricular (RV) dysfunction and ultimately RV failure. Mechanical stimuli …

Lungs are the most vascular part of humans, accepting the totality of cardiac output in a
volume much smaller than the body itself. Due to this cardiac output, the lung …